Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral SteroidsBr Med J 1969; 3 doi: https://doi.org/10.1136/bmj.3.5664.195 (Published 26 July 1969) Cite this as: Br Med J 1969;3:195
- Myron R. Melamed,
- Leopold G. Koss,
- Betty J. Flehinger,
- Richard P. Kelisky,
- Hilliard Dubrow
Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data.
↵* This study was supported in part by USPHS Grant 3421 to Planned Parenthood of New York City, and National Cancer Institute Grant CA 08748 to Sloan-Kettering Institute.